CD8A and heart failure: The survival of the mice that had received OT-I-derived CD8+-T cells before TAC was not different from controls [P = 0.5608; Log Rank (Cox-Mantel) test], suggesting that the ventricular dilation observed in echocardiography does not translate into an enhanced heart failure related mortality.